Pierre-Henri Benhamou
Overview
Explore the profile of Pierre-Henri Benhamou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
503
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Herve P, Dhelft V, Zuniga A, Ghasparian A, Rassek O, Yim K, et al.
Vaccine
. 2021 Jun;
39(32):4555-4563.
PMID: 34154864
Despite the substantial health and economic burden caused by RSV-associated illness, no vaccine is available. The sole licensed treatment (palivizumab), composed of a monoclonal neutralizing antibody, blocks the fusion of...
2.
Dunkin D, Berin M, Mondoulet L, Tobar S, Yeretssian G, Tordesillas L, et al.
Inflamm Bowel Dis
. 2017 Oct;
23(11):1972-1982.
PMID: 29019858
Background: Although inflammatory bowel disease (IBD) is a failure in maintaining tolerance to the intestinal microbiota, few studies have investigated the use of immunologic tolerance as a treatment approach for...
3.
Herve P, Descamps D, Deloizy C, Dhelft V, Laubreton D, Bouguyon E, et al.
J Control Release
. 2016 Nov;
243:146-159.
PMID: 27720994
To put a Respiratory Syncytial Virus (RSV) vaccine onto the market, new vaccination strategies combining scientific and technical innovations need to be explored. Such a vaccine would also need to...
4.
Tordesillas L, Mondoulet L, Blazquez A, Benhamou P, Sampson H, Berin M
J Allergy Clin Immunol
. 2016 Jul;
139(1):189-201.e4.
PMID: 27417020
Background: The attempt to induce oral tolerance as a treatment for food allergy has been hampered by a lack of sustained clinical protection. Immunotherapy by nonoral routes, such as the...
5.
Dioszeghy V, Mondoulet L, Puteaux E, Dhelft V, Ligouis M, Plaquet C, et al.
Cell Mol Immunol
. 2016 Apr;
14(9):770-782.
PMID: 27063469
Allergen-specific immunotherapy has been proposed as an attractive strategy to actively treat food allergy using the following three different immunotherapy routes: oral (OIT), sublingual (SLIT) and epicutaneous (EPIT) immunotherapy. Regulatory...
6.
Jones S, Agbotounou W, Fleischer D, Burks A, Pesek R, Harris M, et al.
J Allergy Clin Immunol
. 2016 Feb;
137(4):1258-1261.e10.
PMID: 26920463
No abstract available.
7.
Mondoulet L, Dioszeghy V, Thebault C, Benhamou P, Dupont C
Immunotherapy
. 2015 Nov;
7(12):1293-305.
PMID: 26584421
Epicutaneous immunotherapy is a developing technique, aiming at desensitizing patients with food allergy with less risks that oral ingestion or injection could generate. Several clinical trials have been performed and...
8.
Gavillet B, Mondoulet L, Dhelft V, Sigrid Eberhardt C, Auderset F, Pham H, et al.
Vaccine
. 2015 Jun;
33(30):3450-5.
PMID: 26067183
The limited durability of pertussis vaccine-induced protection requires novel approaches to reactivate immunity and limit pertussis resurgence in older children and adults. We propose that periodic boosters could be delivered...
9.
Mondoulet L, Dioszeghy V, Puteaux E, Ligouis M, Dhelft V, Plaquet C, et al.
J Allergy Clin Immunol
. 2015 Jan;
135(6):1546-57.e4.
PMID: 25583102
Background: Allergy to cow's milk increases the risk of sensitization to other foods in young children. Objectives: We sought to evaluate the effect of early epicutaneous immunotherapy (EPIT) on further...
10.
Mondoulet L, Dioszeghy V, Ligouis M, Dhelft V, Puteaux E, Dupont C, et al.
ISRN Allergy
. 2013 Jun;
2012:375735.
PMID: 23724241
Background. The aim of this study was to compare the efficacy of epicutaneous immunotherapy (EPIT) to sublingual immunotherapy (SLIT) in a model of mice sensitized to Phleum pratense pollen. Methods....